Please login to the form below

Not currently logged in

Aptiv Solutions promotes Dr Phil Birch and Carolyn Belcher

The US contract research organisation said the appointments fill key strategic posts

US contract research organisation (CRO) Aptiv Solutions has made changes to its executive team, promoting Dr Phil Birch and Carolyn Belcher.

Dr Birch, previously senior vice president of global regulatory at the CRO, will step up to the newly-created position of senior vice president and corporate brand manager for adaptive clinical trials.

In his new role he will focus on brand development, market education and developing strategic partnerships across the business. Prior to joining the company he spent five years at Fulcrum Pharma as general manager, Europe.

Aptiv's other executive change sees former Novartis employee Carolyn Belcher replace Dr Birch as senior director and global head of the Aptiv Solutions Regulatory Business Unit.

Her other previous roles include a stint as a clincial research scientist in the UK's NHS as well as senior director and global head of regulatory affairs and strategic drug development services at SRA Global Clinical Development.

Pat Donnelly, Aptiv's chairman and CEO, said: “This past year, we have seen a dramatic increase in sponsor interest in pursuing adaptive design clinical trials and as an organisation we are aligning strong leadership and expertise to focus internal resources to help our clients develop, design and execute best-in-class adaptive clinical programmes.”

5th December 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Market Access Transformation

MAT offers an information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...